2019
Posted inLewiston-Auburn
Panels differ on recreation spending for Mechanic Falls
Town councilors and the Budget Committee are nearly unanimous on budget recommendations.
advertisement
Posted inLewiston-Auburn, News
Lewiston man’s drug sentence thrown out by high court
David Brown’s conviction of aggravated drug trafficking was found by the state’s highest court to be unproven.
Posted inNation / World, News
Mass shootings at New Zealand mosques kill 49; 1 man charged
Four people in all have been detained by police and more than 48 people were wounded in the attacks.
Posted inFranklin, News
Livermore officials differ on budget recommendations
Selectpersons and the Budget Committee recommend budget cuts for 2019-20.
Posted inLewiston-Auburn
Artist encourages students: ‘Get engaged in some way’
Auburn Middle School students, inspired by Maine artist Robert Shetterly’s portraits, invited him to speak about his work.
Posted inFranklin, News, The Franklin Journal
Chesterville home burns
Firefighters from several departments responded to a fire at 168 East Road in Chesterville, near the Fayette town line.
Posted inBusiness
Auburn businesswoman opens secondhand store to benefit opiate recovery
Debra York is opening A Second Chance Retail in the Gridiron Plaza on outer Lisbon Street in Lewiston and earmarking proceeds for Operation HOPE (Heroin-Opiate Prevention Effort) and its partner, Portland Recovery Community Center.
Posted inLewiston-Auburn
Celebrating Francophone Month in Lewiston
Wyatt Ashbaugh, 9, of Portland narrates the production of “C’est moi le plus fort” (I am so Strong) at the Gendron Franco Center in Lewiston on Thursday. Ashbaugh is one of 70 students from the French-immersion school, l’Ecole Française du Maine, who presented the performance in French to help celebrate Francophone Month. School co-founder Willy […]
Posted inMaine, News, Politics
Patients ask Legislature to restrict insurers’ control over medications
But an insurance industry representative argues that a bill to regulate ‘step therapy’ would favor ‘costlier, but no more therapeutically effective, brand name drugs.’